Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arteris (AIP) Research & Development (2024 - 2025)

Arteris' Research & Development history spans 2 years, with the latest figure at $13.2 million for Q4 2025.

  • For Q4 2025, Research & Development rose 14.7% year-over-year to $13.2 million; the TTM value through Dec 2025 reached $49.6 million, changed N/A, while the annual FY2025 figure was $49.9 million, 10.89% up from the prior year.
  • Research & Development reached $13.2 million in Q4 2025 per AIP's latest filing, up from $12.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13.2 million in Q4 2025 to a low of $10.7 million in Q2 2024.